Hypertension in pregnancy is associated with elevated homocysteine levels later in life.

[1]  O. Kandemir,et al.  Maternal cardiac risks in pre-eclamptic patients , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  M. Kurdoğlu,et al.  Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy , 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[3]  S. Joshi,et al.  Association of omega-3 fatty acids and homocysteine concentrations in pre-eclampsia. , 2011, Clinical nutrition.

[4]  S. Pençe,et al.  Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre‐eclampsia , 2011, The journal of obstetrics and gynaecology research.

[5]  A. Biri,et al.  Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women , 2010, Archives of Gynecology and Obstetrics.

[6]  Eric Boerwinkle,et al.  Hypertension in pregnancy as a risk factor for cardiovascular disease later in life , 2010, Journal of hypertension.

[7]  L. Smits,et al.  Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. , 2010, American journal of obstetrics and gynecology.

[8]  P. Kenemans,et al.  Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. , 2008, Fertility and sterility.

[9]  R. Singh,et al.  A study of changes in homocysteine levels during normal pregnancy and pre-eclampsia. , 2008, Journal of the Indian Medical Association.

[10]  H. Ayatollahi,et al.  Elevated plasma total homocysteine in preeclampsia. , 2008, Saudi medical journal.

[11]  S. Turner,et al.  Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. , 2008, American journal of obstetrics and gynecology.

[12]  V. Garovic,et al.  Pre-Eclamptic Pregnancies: An Opportunity to Identify Women at Risk for Future Cardiovascular Disease , 2008, Women's health.

[13]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[14]  D. Arduini,et al.  Single inherited thrombophilias and adverse pregnancy outcomes , 2007, The journal of obstetrics and gynaecology research.

[15]  J. Moutquin,et al.  Previous Hypertensive Disease of Pregnancy Is Associated With Alterations of Markers of Insulin Resistance , 2007, Hypertension.

[16]  C. Luley,et al.  Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels , 2007, Vascular health and risk management.

[17]  A. Makedos,et al.  Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia , 2007, Archives of Gynecology and Obstetrics.

[18]  S. Jeng,et al.  Severe obstetric complications and birth characteristics in preterm or term delivery were accurately recalled by mothers. , 2006, Journal of clinical epidemiology.

[19]  P. Latthe,et al.  Mapping the Theories of Preeclampsia: The Role of Homocysteine , 2005, Obstetrics and gynecology.

[20]  R. Ness,et al.  Homocysteine and Folic Acid Are Inversely Related in Black Women With Preeclampsia , 2004, Hypertension.

[21]  R. Ientile,et al.  Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction , 2004, Acta obstetricia et gynecologica Scandinavica.

[22]  J. Cooke,et al.  Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine , 2003, Circulation.

[23]  E. Steegers,et al.  Hyperhomocysteinaemia: a risk factor for preeclampsia? , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[24]  U. Turpeinen,et al.  Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. , 2000, Fertility and sterility.

[25]  S. Brennecke,et al.  C677T Methylenetetrahydrofolate Reductase Polymorphism Is Not a Risk Factor for Pre-Eclampsia/Eclampsia among Australian Women , 2000, Human Heredity.

[26]  R. Goldenberg,et al.  Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction. , 2000, American journal of obstetrics and gynecology.

[27]  M. Murphy,et al.  Homocysteine in pregnancy. , 2011, Advances in clinical chemistry.

[28]  K. Spencer,et al.  Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia. , 2004, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[29]  Steven C. Hunt,et al.  Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP). , 2002, Hypertension.

[30]  K. Raphael.  Differential recall as a source of bias. , 1991, Journal of clinical epidemiology.